PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19957722-2	2009	It is established, that among components of antiulcerous therapy such as omeprazole, clarithromycin and metronidazole inhibit content and activity of MOS enzymes.	Metronidazole	104-117	MOS proto-oncogene, serine/threonine kinase	Rattus norvegicus	150-153	
19957722-5	2009	In triple therapy with omeprazole, clarithromycin and metronidazole the inhibit effect of preparations to system of MOS is exponentiated and it leads to suppression of mucous cytoprotaction of gastro duodenal zone.	Metronidazole	54-67	MOS proto-oncogene, serine/threonine kinase	Rattus norvegicus	116-119